NantHealth, Inc. (9)

Browse by Contract Category

Business Finance (5)
Uncategorized (4)

Contracts

Form of Exchange Agreement by and between the Company and (Filed With SEC on April 14, 2021)
Description of Securities (Filed With SEC on February 26, 2021)
Form of Exchange Agreement by and between the Company and certain holders, dated as of April 1 (Filed With SEC on April 14, 2021)
Amended and Restated Promissory Note by and between the Company and Nant Capital, LLC dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
Amendment No. 3 to Second Amended and Restated NantOmics Exclusive Reseller Agreement dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
Open NMS Assignment Agreement, dated as of July 22, 2020, between the Registrant and Cambridge Equities, LP (Filed With SEC on August 10, 2020)
Description of Securities (Filed With SEC on February 28, 2020)
Asset Purchase Agreement dated as of January 13, 2020, among Masimo Corporation and VCCB Holdings, Inc., and NantHealth, Inc (Filed With SEC on February 28, 2020)
Amendment no. 2 to Second Amended and Restated Nantomics Exclusive Reseller Agreement (Filed With SEC on May 9, 2019)